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During brain wiring, cue-induced axon behaviors
such as directional steering and branching are aided
by localized mRNA translation. Different guidance
cues elicit translation of subsets of mRNAs that
differentially regulate the cytoskeleton, yet little is un-
derstood about how specific mRNAs are selected for
translation. MicroRNAs (miRNAs) are critical transla-
tional regulators that act through a sequence-spe-
cific mechanism. Here, we investigate the local role
of miRNAs in mRNA-specific translation during path-
finding of Xenopus laevis retinal ganglion cell (RGC)
axons. Among a rich repertoire of axonal miRNAs,
miR-182 is identified as the most abundant. Loss of
miR-182 causes RGC axon targeting defects in vivo
and impairs Slit2-induced growth cone (GC) repul-
sion. We find that miR-182 targets cofilin-1 mRNA,
silencing its translation, and Slit2 rapidly relieves
the repression without causing miR-182 degrada-
tion. Our data support a model whereby miR-182
reversibly gates the selection of transcripts for fast
translation depending on the extrinsic cue.
INTRODUCTION
The accurate wiring of the nervous system depends on the ability
of axons to extend from neuronal somata to reach their specific
synaptic targets during development. Growth cones (GCs) lead
growing axons to their correct destinations by responding direc-
tionally to attractive and repulsive cues encountered along the
pathway (Bouquet and Nothias, 2007). Given the extreme dis-
tance that can separate pre- and post-synaptic populations of
neurons, axon pathfinding presents a unique challenge for neu-
rons in ensuring that GCs respond properly and rapidly to guid-
ance stimuli. During recent years, it has become clear that axonsCell Re
This is an open access article undand GCs possess a high degree of functional autonomy and that
this is aided by local protein synthesis (LPS) (Holt and Schuman,
2013). A complex and changing repertoire of mRNAs is trafficked
into growing axons andGCs (Zivraj et al., 2010; Gumy et al., 2011,
2014), where some are locally translated in response to guidance
cues independent of cell bodies (Campbell and Holt, 2001; Brittis
et al., 2002; Yao et al., 2006; Lin and Holt, 2007). Studies investi-
gating LPS regulation in axons have linked guidance signaling
with the regulation of global translational activity in the GC,
such as the activation of the initiation factor eIF-4E (eukaryotic
initiation factor 4E) (Campbell and Holt, 2001; Piper et al., 2006),
or the sequestration of ribosomal components (Tcherkezian
et al., 2010). However, evidence points to a selective model of
translation whereby specific subsets of mRNAs from a complex
mRNA pool (Lin and Holt, 2007; Deglincerti and Jaffrey, 2012)
are differentially translated in response to different extrinsic
cues while others remain translationally silent. For example,
Slit2 and Semaphorin3A (Sema3A) mediate GC repulsion via
the translation of cofilin-1 (Cfl1) and RhoA (Piper et al., 2006;
Wu et al., 2005), respectively, whereasNetrin-1 and brain-derived
neurotrophic factor (BDNF) promote attraction by the local syn-
thesis of b-actin (Leung et al., 2006; Yao et al., 2006). A major un-
resolved question is how a given transcript is specifically selected
for translation in GCs in response to a given guidance cue.
Although extrinsic cues facilitate mRNA-specific translation in
GCs through the regulation of RNA-binding protein (RBP)-medi-
ated axonal transport (Vuppalanchi et al., 2009), no mechanisms
directly regulating the translation of specific mRNAs in the GC
have been identified so far for directional steering. Moreover,
given the complex nature of mRNA translation in developing
axons (Shigeoka et al., 2013), RBPs alone are unlikely to account
fully for the complex regulation of mRNA-specific translation in
GCs during guidance, and additional layers of regulation are
probably involved.
MicroRNAs (miRNAs) have emerged as key translational
regulators possessing mRNA target specificity. miRNAs are first
transcribed as long primary molecules, pri-miRNAs, and then
processed by Drosha and Dicer to generate mature miRNAports 18, 1171–1186, January 31, 2017 ª 2017 The Authors. 1171
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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molecules (Kim et al., 2009). These non-coding 21 nt long mol-
ecules bind to complementary sequences on mRNAs (Bartel,
2009) and modulate their stability and/or translation (Bazzini
et al., 2012; Djuranovic et al., 2012; Eichhorn et al., 2014). Due
to the sequence-specific regulation of mRNA translation by
miRNAs, one way to control mRNA-specific translation during
axonguidancecouldbe regulationbymiRNAs.Several linesofev-
idence suggest that miRNAs are involved in axon guidance and
GCsteering, but theirmechanismof action remains poorly under-
stood (Iyer et al., 2014). First, in mouse, the absence of Dicer in-
duces severe axon pathfinding defects in the visual pathway
in vivo (Pinter and Hindges, 2010). Second, in Xenopus retinal
axons, miR-124 regulates the onset of expression of neuropilin1
(Sema3A receptor) and controls a Sema3A-mediated guidance
decision in vivo (Baudet et al., 2011). Finally, miR-134 is required
in Xenopus spinal neurons for BDNF-induced GC steering in vitro
(Han et al., 2011). miRNAs (Hancock et al., 2014; Natera-Naranjo
et al., 2010; Sasaki et al., 2014) and the functional RNA-induced
silencing complex (RISC) (Hengst et al., 2006) have been shown
to reside in developing axons, suggesting that miRNAs may act
locally within this neuronal compartment.
Here we have investigated whether miR-182, identified from
an axonal profiling screen, can regulate the guidance of Xenopus
retinal ganglion cell (RGC) axons in the visual pathway by modu-
lating the axonal translation of specific mRNAs. We show that
miR-182 depletion causes RGC axon targeting defects in vivo
that phenocopy Slit2 knockdown in the brain. In the absence
of miR-182, protein synthesis-dependent GC repulsive steering
in response to Slit2 is abolished. Furthermore, we demonstrate
that miR-182 directly targets Cfl1 mRNA, a key cytoskeleton
regulator, and is required for Slit2-induced axonal Cfl1 synthesis.
Finally, we show that Slit2 inhibits the activity of miR-182 in GCs,
without degrading it. We propose that under basal conditions,
axonal miR-182 represses the de novo synthesis of Cfl1 in the
GC. Upon Slit2 stimulation, miR-182 is inactivated, temporarily
relieving Cfl1 mRNA from its repression and allowing its local
translation, which facilitates the cytoskeletal changes that un-
derlie directional steering.
RESULTS
Growing RGC Axons Contain a Rich Repertoire of
miRNAs
To characterize the full repertoire of miRNAs in developing RGC
axons, we performed an unbiased analysis of miRNAs residing
in the axonal compartment using Illumina Next-Generation
Sequencing technology. To obtain sufficient axonal material,
1,000 eyes from stage 37/38 (according toNieuwkoop and Faber,
1994)Xenopus larvaewere cultured for 48 hr for each experiment.
Intact eyes were explanted with the optic nerve exit point (back ofFigure 1. miR-182 Is Localized in RGC Axons
(A) Heatmap representing the average expression of mature miRNAs from two a
retinal cultures. The figure is sorted by decreasing axonal average values.
(B) Fluorescent ISH on stage 35/36 RGC GCs cultured in vitro for 24 hr.
(C) TaqMan qPCR performed on RNA extracted from laser-captured stage 37/3
developing axons (Natera-Naranjo et al., 2010; Zhang et al., 2013; Hancock et a
RT, no template negative control; snRNAU6, U6 snRNA. Scale bar, 5 mm (B). Seye) positioned in contact with the culture substrate to facilitate
the outgrowth, exclusively, of RGC axons. RGC axons were sub-
sequently harvested from the culture substrate by manual
removal of the explanted eyes (Figures S1A and S1B). This
approach has been used previously to successfully obtain pure
axon material (Yoon et al., 2012). The purity of the axonal material
was validated by RT-PCR, which showed the presence of b-actin
mRNA, known to be expressed in developing axons (Leung et al.,
2006), and the absence of microtubule-associated protein 2
(MAP2) transcript, whose expression is known to be restricted
to cell bodies and dendrites (Figure S1C) (Kleiman et al., 1990). Li-
braries from two biological replicates of 22–30 nt gel-excised
small RNAs were sequenced. The two libraries yielded 7.8 and
10.8 million reads and revealed the presence of 148 miRNAs in
growing RGC axons, with at least 1 read in both replicates (Fig-
ure 1A; Table S1). The two replicates were highly correlated, as
judged by the expression level of all miRNAs (Pearson’s correla-
tion coefficient = 0.93) (Figure S1D). The most abundant miRNAs
detected were miR-182, miR-181a, miR-181b, miR-92a, miR-
184, and miR-183, representing 25%, 17.8%, 7.9%, 4.6%,
3.9%, and 3.8%, respectively, of the total miRNAs in developing
RGC axons (Figure 1A). In situ hybridization (ISH) experiments
were performed to validate the sequencing results. We success-
fully detected the presence of an ISH signal in cultured RGC
axons andGCs for the 15most abundant sequenced axonal miR-
NAs, as well as for the brain-specific miRNA miR-9 (Figure 1B)
(data not shown). In contrast, no signal was detected when using
a control probe or a probe against miR-187, a miRNA not de-
tected in RGC axons by sequencing (Figure 1B).
Analysis of the RNA sequencing (RNA-seq) results identified
miR-182 as the most abundant axonal miRNA. Its presence in
axons was validated using ISH (as described earlier) (Figure 1B)
and qPCR from axons collected by laser capture microdissec-
tion (LCM) (Figure 1C). Although miR-182 presence was unde-
tectable in RGC soma through ISH in vivo (Figure S2B), the pres-
ence of miR-182 in axons suggests that it is, at least transiently,
expressed in the RGCcell body. TaqMan qPCR, amore sensitive
detection method, detected miR-182 in RGC soma in vivo,
collected by LCM (average Ct: 27.65 ± 1.52; positive control
U6 small nuclear RNA [snRNA], average Ct: 23.26 ± 0.61) (Fig-
ure S1E). In comparison with whole eye, miR-182 showed an
average 8.0 ± 2.31-fold depletion in RGC soma using the DDCt
method, with U6 snRNA as a normalizer. Because eye cells
also comprise many non-miR-182-expressing or poorly miR-
182-expressing cells, this is a likely underestimation of the extent
of miR-182 depletion in RGC soma compared to miR-182-ex-
pressing photoreceptor cells.
We next addressed whether miR-182 activity reflects its com-
partmentalized distribution using a reporter sensor of miRNA ac-
tivity, similar in design to a previously used construct (De Pietrixonal small RNA-sequencing (sRNA-seq) libraries prepared from stage 37/38
8 RGC axons. U6 snRNA was used as positive control, because it is found in
l., 2014).
ee also Figure S1 and Table S1.
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Figure 2. miR-182 Is Active and Enriched in RGC Axons
(A) Sensor construct design.
(B) Schematic representation of the experimental protocol.
(C–E) Illustrative images of RGC GCs (C), RGC soma (D), or PRs (E) following retinal electroporation of control-Sensor or miR-182-Sensor. Clear examples of
dGFP/mCherry ratio decrease are shown in (C) and (E).
(legend continued on next page)
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Tonelli et al., 2006). miR-182-Sensor expresses destabilized
GFP (dGFP) under the regulation of a 30 untranslated region
(30 UTR) containing three sequences complementary to miR-
182, withmCherry as an internal control (Figure 2A). Any increase
in miR-182 activity should lead to the decrease of dGFP while
leaving mCherry expression levels unaltered. In control-Sensor,
the three sequences complementary to miR-182 are replaced
by scrambled sequences. It should thus be inert to change in
miR-182 activity.
Sensor sensitivity was first validated in vivo in photoreceptors
(PRs), where miR-182 is abundantly expressed (Figure S2B).
Electroporation of sensors into stage 26 eyes and comparison
of the dGFP/mCherry ratio in stage 41 retinas shows that the
dGFP/mCherry ratio from miR-182-Sensor, but not from con-
trol-Sensor, is significantly decreased in PRs (61% ± 0.02%)
but not in amacrine-like cells (+1% ± 0.07%) (Figures S2A and
S2C–S2E). This suggests that miR-182-Sensor specifically de-
tects endogenous miR-182 activity in PRs in vivo but not in cells
with no or low miR-182 expression.
To explore the compartmentalized action of miR-182 activity,
we measured miR-182 activity in retinal explant-derived RGC
soma and axons. The evaluation of local regulation of dGFP
and mCherry transcripts in axons was possible, because dGFP
and mCherry mRNAs are detected in this compartment (Fig-
ure S2F). Sensor-electroporated retinas were thus cultured at
stage 35/36, and the fluorescence levels of dGFP and mCherry
were measured directly in RGC GCs or in RGC soma and PRs
of cryosectioned explants (Figure 2B). Quantification reveals
that while the dGFP/mCherry ratio of control-Sensor remains
unchanged between both cell types and compartments, the
ratio of miR-182-Sensor is significantly decreased in RGC axons
(31% ± 8.1%) and PRs (73.3% ± 0.04%) but not in RGC
soma (+33.4% ± 0.11%) (Figures 2C–2G). This indicates that
miR-182 is specifically active in the axonal compartment of
RGCs but not in the soma.
Altogether, these results confirm the enrichment and activity
of miR-182 in RGC axons and GCs and the reliability of our
sequencing results.
miR-182 Regulates Axon Targeting in the Optic Tectum
In Vivo
To assess whether miR-182 plays a role in RGC axon guidance
in vivo, we used a loss-of-function approach in the Xenopus
visual system using miRNA antisense morpholino oligomers
(MOs) and axon tracing. A miR-182 MO blocking the function
of endogenous mature Xenopus laevis (xla) xla-miR-182 was in-
jected into the dorsal blastomeres of eight-cell-stage embryos
(Figure S3A). These two dorsal blastomeres are fated to give
rise to the entire CNS; therefore, targeting them for MO delivery
induces specific knockdown in the CNS, including the neural
retina, at later stages (Leung and Holt, 2008). At stage 37/38,
miR-182 morphants show almost no expression of miR-182 in
the CNS by ISH. In contrast, control embryos show expression(F and G) Quantification of the dGFP/mCherry ratio at the RGC GCs, soma, or P
Values are mean ± SEM. Mann-Whitney test (F) and two-way ANOVA followed b
cytomegalovirus promoter; CS, complementary sequence; dGFP, destabilized G
cell layer. Scale bars, 20 mm (B, D, and E) and 5 mm (C). See also Figure S2.of miR-182 in the outer retina and different regions of the brain,
such as the pineal gland, the otic vesicle, or the olfactory pit
areas (Figure S3B), consistent with previously reported expres-
sion of miR-182 (Wei et al., 2015). This result indicates that injec-
tion of miR-182 MO at the eight-cell stage efficiently knocks
down endogenous miR-182 until later developmental stages.
No gross morphological defects were observed in miR-182 mor-
phants (Figure S3A). The eye size and the number of RGCs,
counted as Islet-1 positive/Sox2 negative cells on cryosections
at stage 40 (Baudet et al., 2011), were similar to controls (Figures
S3C–S3E). Altogether, these results indicate that the knockdown
of miR-182 in the CNS does not affect the gross development of
the eye or the maturation of RGCs.
Next, we investigated whether miR-182 is involved in the path-
finding of RGC axons in vivo. During development, pioneering
RGC axons exit the eye at stage 28, cross the optic chiasm at
stage 32, and grow dorsally to project to their midbrain target,
the optic tectum, at stage 37/38. By stage 40, most axons from
the central retina have reached their final destination (Holt,
1989). miR-182 morphants and control embryos were raised to
stage40, andRGCaxonswereanterogradely labeledby lipophilic
DiI filling of the eye (Figure 3A). In miR-182 morphant embryos,
RGC axons project appropriately through the optic pathway on
the contralateral side of the brain (Figure 3A), and no difference
in RGC axon length is observed between control and miR-182
MO-injected embryos (Figures 3B, S3F, and S3G). This suggests
that miR-182 is not essential for growth and long-range path-
finding of RGCaxons to the tectal area. However, immediately af-
ter entering the tectum, the trajectories of theRGCaxon terminals
appear to dispersemorewidely inmiR-182morphants (Figure 3A,
insets) with axons often straying aberrantly toward the dorsal
midline. The width of the DiI-labeled RGC axon pathway was
measured at regular intervals from the optic chiasm to the tectal
posterior boundary. Those intervals were defined by tracing ten
concentric circles from theoptic chiasm to theposteriorboundary
of the tectum, and tract widths were measured as the distance
between the two outermost axons intersecting each circle. The
width was normalized to the size of the brain measured from the
optic chiasm to the posterior boundary of the tectum (Figure 3B).
Quantification shows that the RGC axon pathway width of mor-
phant embryos is similar to controls in the optic tract but is
increased (by up to 35%, 40 mm) in the tectal region. This indi-
cates that RGC axons of miR-182 morphants are appropriately
bundled along the optic tract but that they project more expan-
sively across the tectum compared to controls (Figure 3B), sug-
gesting that miR-182 is involved in restricting the targeting area
of RGC axons within the tectum. Though the described axon
defect appears modest in terms of size, in comparison to the
size, approximately 150 mm, of the tectal neuropil at this age,
this 40 mm expansion of the projection in the target represents a
significant change in retinotectal connectivity.
Because the blastomere microinjection approach targets the
entire CNS, the axonal phenotype could be attributed to a lossRs.
y Tukey post hoc test (G), *p < 0.05, ****p < 0.0001. ns, nonsignificant; CMV,
FP; INL, inner nuclear layer; PRL, photoreceptor layer; RGCL, retinal ganglion
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Figure 3. In Vivo, miR-182 Is Involved in RGC Axon Targeting but Not Long-Range Pathfinding
(A, C, and E) Schematic representation of the experimental protocols and representative images of brains, where RGC axons are stained with DiI or expressing
mCherry. Arrows delineate the width of the pathway (A).
(B, D, and F) Quantification of pathway width. (B) Schematic representation of the methodology applied for pathway width measurements.
Values are mean ± SEM. Numbers of brains analyzed are between brackets. Two-way ANOVA followed by Bonferroni post-test, *p < 0.05, **p < 0.01. Cont,
control; MO, morpholino oligomer; RGC, retinal ganglion cell. Scale bars, 150 mm (A, top panels) and 50 mm (A, bottom panel; C; and E). See also Figure S3.
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of function of miR-182 in the RGCs (i.e., autonomous) or in the
cells forming the pathway substrate in the brain (i.e., non-auton-
omous), although the latter possibility is rather unlikely due to the
absence of miR-182 expression in the midbrain. To formally
distinguish between these possibilities, we abolished miR-182
function specifically in retinal cells by electroporating miR-182
MO, plus a mCherry reporter, into stage 26 eye primordia
when RGC axonogenesis is just beginning. The phenotype of
miR-182 MO eye-electroporated embryos was similar to that
of blastomere-injected miR-182 morphants, with both exhibiting
an expanded RGC axon targeting area in the tectum (Figures 3C,
3D, and S3H). Finally, to validate the specificity of the miR-182
MO,we performed rescue experiments by electroporating retinal
cells of stage 26 morphant embryos with miR-182 mimic or con-
trol mimic. The electroporation of miR-182mimic, but not control
mimic, induced a re-expression of miR-182 in retinal cells (Fig-
ure S3I) and rescued the guidance phenotype of miR-182-
depleted RGC axons in the tectum (Figures 3E and 3F). This con-
firms that the phenotype observed in miR-182 morphants is due
to the specific knockdown of this miRNA in retinal cells. Alto-
gether, these data show that, in vivo, miR-182 acts cell autono-
mously in RGCs to delimit axons to a restricted area within the
tectum.
miR-182 Modulates RGC GC Responsiveness to Slit2
The aberrant expansion of the projection observed in the miR-
182 morphant tecta suggests that miR-182 may regulate the
responsiveness of RGC axons to tectal repulsive cues that
restrict the targeting area. Among multiple cues expressed
within the tectum, the repulsive cue Slit2 is known to play a
role in confining the growth of axons to specific areas (Erskine
et al., 2000; Piper et al., 2006). Therefore, we hypothesized
that Slit2 is involved in delimiting the RGC axon-recipient area
of the tectum. To test this, we first asked whether loss of Slit2
in the brain causes a phenotype similar to that seen with miR-
182 depletion. MO successfully blocked Slit2 translation (Fig-
ure S4). To achieve Slit2 knockdown in the brain, but not in the
eye, control wild-type eyes were transplanted into Slit2 mor-
phant host embryos at stage 24 and the RGC axon projections
were subsequently assessed at stage 40 by DiI anterograde la-
beling (Figure 4A). In these embryos, RGC axons grow appropri-
ately through the optic tract but project over a larger area in the
tectum (Figures 4A and 4B), confirming the function of Slit2 as a
target-restricting cue for RGC axons in vivo. This phenotype is
similar to miR-182 morphant eye projections (Figure 3), consis-
tent with the possibility that miR-182 interacts with Slit2 signaling
in RGC axons. Moreover, covisualization of Slit2 (ISH) and RGC
axons (horseradish peroxidase [HRP] anterograde labeling) at
stage 40 shows that RGC axons grow closer to the Slit2-ex-
pressing tectal territory in miR-182 morphants than in control
embryos, with some axons even invading Slit2 domains (Figures
4C and 4D). These results indicate that miR-182-depleted RGC
axons fail to respond appropriately to Slit2 in vivo, resulting in
targeting defects.
To test whether miR-182 alters axonal Slit2 sensitivity, we
used the GC turning assay (Lohof et al., 1992). Stage 35/36
eye explants were cultured for 24 hr, a period that corresponds
to the time when the RGC axons are beginning to enter the optictectum in vivo (Piper et al., 2006). Turning assays were per-
formed on axons severed from their cell bodies to exclude
soma-derived effects. Control RGC axons showed robust repul-
sive turning from the Slit2 gradient (average turning angle of
18.7 ± 5.28) (Figures 4E–4G) (Piper et al., 2006). By contrast,
miR-182 morphant axons failed to exhibit a turning response to
a Slit2 gradient (average turning angle of +1.91 ± 3.58). These
results show that Slit2-induced repulsive turning requires
miR-182 activity and that this requirement is local. However,
miR-182 morphant axons are still repelled by Sema3A, another
guidance cue involved in target restriction in the tectum (Figures
S5A–S5C). Thus, axonally localized miR-182 appears to regulate
the responsiveness of GCs specifically to Slit2.
miR-182 Regulates Slit2-Induced Cfl1 mRNA
Translation
We next examined the mechanisms of action of miR-182 as a
modulator of Slit2-induced axon guidance and targeting. Slit2-
induced repulsive turning of RGC GCs is reported to be depen-
dent upon LPS (Piper et al., 2006). Given the preceding findings,
we reasoned that axonal miR-182maymediate Slit2 signaling by
targeting mRNAs that are locally translated in RGC GCs in
response to Slit2.
To gain insight about miR-182 putative targets in axons, we
use our recently developed algorithm, TargetExpress (Ovando-
Vázquez et al., 2016). We identified 1,064 potential miR-182 tar-
gets expressed in Xenopus RGC growth cones (Zivraj et al.,
2010) (see Supplemental Experimental Procedures for details).
Pyruvate dehydrogenase kinase 4, a metabolic enzyme with no
known activity in axons and no known link to Slit2, has the high-
est probability and Cfl1 has the second-highest probability of
miR-182 targeting (Figure 5A; Table S2). The 30 UTR of Cfl1
mRNA is predicted to contain one highly conserved miR-182
8-mer binding site (Figure 5B). Slit2 induces the local synthesis
of Cfl1, a regulator of actin cytoskeleton dynamics, in GCs,
and this is known to mediate RGC GCs’ repulsive responses to
Slit2 (Piper et al., 2006). We thus hypothesized that miR-182
modulates GC responsiveness to Slit2 by locally silencing Cfl1
mRNA translation.
To assess this, we first validated that Xenopus laevis Cfl1-30
UTR is a bona fide target of miR-182 through a dual Renilla:
Firefly luciferase reporter assay in HEK293T cells. Cfl1-30 UTR
was subcloned downstream of Renilla luciferase (Figure 5C).
With this dual luciferase construct, the expression and activity
of the Renilla luciferase depends on Cfl1-30 UTR regulation,
whereas the Firefly luciferase activity is independent. The dual
luciferase reporter was transfected into HEK293T cells, along
with miR-182 or control mimic, and the activity of both lucifer-
ases was measured. The expression of miR-182, but not the
control mimic, induced a significant decrease in the Renilla/
Firefly activity ratio (28.8% ± 2.7%) (Figure 5D). However, the
control miR-182 mimic had no significant effect on the Renilla/
Firefly activity ratio when the predicted miR-182 site of Cfl1-30
UTRwas mutated (Figures 5B–5D). This assay showed that Xen-
opus laevis Cfl1 mRNA is directly targeted and silenced by miR-
182 through its predicted binding site.
We next determined whether miR-182 directly regulates Cfl1
expression levels in RGCGCs. As a first approach, wemeasuredCell Reports 18, 1171–1186, January 31, 2017 1177
Figure 4. miR-182 Is Involved in Slit2-Driven RGC Axon Guidance and Targeting In Vivo and In Vitro
(A) Schematic representation of the experimental protocol and representative images of brains, where RGC axons are stained with DiI.
(B) Quantification of pathway width. Numbers of brains analyzed are between brackets.
(C and D) Schematic representation of the experimental protocols (C) and representative images (D) of brains, where RGC axons are stained with HRP and Slit2
mRNAs are revealed by ISH.
(E–G) In vitro turning assay on stage 35/36 RGC axons cultured for 24 hr and isolated from their cell bodies. (E) Representative images of control of miR-182
morphant RGC GC before and 60 min after being exposed to a gradient of Slit2 established from a pipette (top right corner) set at 45 angle from the initial
(legend continued on next page)
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Figure 5. miR-182 Targets Cfl1 mRNA and Regulates Its Expression in RGC Axons
(A) Top predicted miR-182 targets expressed in Xenopus laevis growth cones.
(B) Sequence alignment of the 30 UTR of Cfl1. The predicted miR-182 binding site is highlighted in red.
(C) Schematic representation of Xenopus Cfl1-30 UTR, subcloned downstream of a dual Renilla:Firefly luciferase reporter.
(D) Quantification of reporter activity in HEK293T cells.
(E and F) Representative images (E) and quantification (F) of Cfl1 immunostaining. White lines delineate RGC growth cones. Bath application of Slit2 was used at a
suboptimal concentration to avoid collapse.
Values are mean ± SEM (D and F). Numbers of GCs analyzed are indicated in bars (F). ANOVA followed by Bonferroni post-test, ***p < 0.001. ns, nonsignificant;
cfl1, Cfl1; cont, control; MO, morpholino oligomer; MUT, mutated; WT, wild-type. Scale bar, 5 mm (E). See also Table S2.by quantitative immunostaining the expression level of Cfl1 pro-
tein in RGC GCs of control or miR-182 morphants (Figures 5E
and 5F). Under basal conditions, Cfl1 expression is significantly
increased in miR-182 morphant GCs (+45% ± 7%), indicatingdirection of growth. (F) Tracings of RGC axons are analyzed. The source of the guid
respectively, repulsive behaviors (angle < 5), nonsignificant changes in the d
Quantification of the average turning angle. Numbers of GCs analyzed are betwe
Values are mean ± SEM (B and G). Two-way ANOVA followed by Bonferroni pos
horseradish peroxidase; ISH, in situ hybridization; MO, morpholino oligomer; RG
panel, and D), and 30 mm (E). See also Figures S4 and S5.that miR-182 represses Cfl1 mRNA in the absence of a stimulus,
maintaining a dormant state. After stimulation by Slit2, Cfl1 levels
significantly increase (+45.7% ± 5%) in control RGC GCs, as
previously reported (Piper et al., 2006). In contrast, in theance cue is indicated by the arrowhead. Red, black, and blue traces represent,
irection of growth (5 < angle < 5), and attractive turning (angle > 5). (G)
en brackets.
t-test (B) or Mann-Whitney test (G), *p < 0.05, **p < 0.01. Cont, control; HRP,
C, retinal ganglion cell. Scale bars, 150 mm (A, top panels), 50 mm (A, bottom
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Figure 6. miR-182 Is Required for Slit2-Induced Local Translation of Cfl1 in RGC GCs
(A) Schematic representation of the experimental protocol. After 24 hr, RGC axons were isolated from their cell bodies. Bath application of Slit2 at a suboptimal
concentration was used to avoid collapse. Vehicle was used as control. Recovery of the newly synthesized Kaede green protein was monitored over time.
(B) Quantification of the recovery of Kaede green signal. Data are presented as the percentage change of the fluorescence intensity (F) over time. Numbers of GCs
analyzed are indicated in the legend of the graph.
(C and D) Representative pre- and post-photoconversion images of severed control (C) or miR-182 morphant (D) axons.
Values are mean ± SEM (B). Kruskal-Wallis test, *p < 0.05, **p < 0.01. Scale bars, 10 mm (C and D). Cont, control; LPS, local protein synthesis; MO, morpholino
oligomer. See also Figure S6.absence of miR-182, Slit2 stimulation does not induce any
further increase of Cfl1 protein level in RGC GCs (Figures 5E
and 5F). Our results thus further indicate that miR-182 is required
to mediate a Slit2-induced increase of Cfl1 expression in the GC.
The increase of Cfl1 protein in the GC after Slit2 stimulation
is consistent with de novo protein synthesis of Cfl1 in GCs. Alter-
natively, it may be due to increased transport of preexisting
proteins from the axonal shaft. To distinguish between these
possibilities, we tested directly whether miR-182 modulates
Slit2-induced local de novo protein synthesis of Cfl1. To do so,
a Kaede protein-based translation reporter (Leung and Holt,
2008) was generated to visualize live Cfl1 de novo protein syn-
thesis in isolated GCs after Slit2 stimulation in vitro. The green
fluorescence of native Kaede can be proteolytically and irrevers-
ibly photoconverted to red by UV illumination, and subsequent
recovery of a green signal enables the detection of newly synthe-1180 Cell Reports 18, 1171–1186, January 31, 2017sized protein versus pre-existing protein. Because the miR-182
binding site is located in the Cfl1-30 UTR, we made a reporter
construct with the Kaede sequence linked to the 30 UTR of Cfl1
mRNA (Kaede-Cfl1-30 UTR). The Kaede-Cfl1-30 UTR reporter
construct was electroporated into the eye primordia of control
or miR-182 morphant embryos at stage 26, and 12 hr later,
eyes were explanted and grown for 24 hr in culture. To verify
that the reappearance of the green signal was due to LPS specif-
ically within theGC and not to transport from the cell body, axons
were isolated from their cell bodies (Figure 6A). Under basal con-
ditions, miR-182 morphant GCs exhibited a significantly higher
basal level of Kaede fluorescence (+29% ± 9%) (Figure S6),
consistent with our finding that miR-182 silences Cfl1 mRNA
(Figure 5). For the green/red ratio comparative analysis, the in-
tensity of the Kaede green signal was normalized to its intensity
before photoconversion. In control GCs, the Kaede green signal
reappears progressively after Slit2 stimulation (15.7% ± 3.7%, at
30 min), while no significant recovery is seen without stimulation
(0.7% ± 0.3%, at 30 min). This confirms that Slit2 induces Cfl1
local translation directly in RGC GCs. In contrast, in the absence
of axonal miR-182, no significant reappearance of the Kaede
green signal is observed during the 30 min of imaging with or
without stimulation by Slit2 (Figures 6B–6D), indicating that
miR-182 is required to mediate Slit2-induced LPS of Cfl1 in
RGC GCs in vitro.
Collectively, these results show that miR-182 modulates
Cfl1 translation in RGC axons by both silencing Cfl1 mRNA
under basal conditions and enabling its translation upon Slit2
stimulation.
Slit2 Modulates miR-182 Activity in RGC GCs
The finding that miR-182 is a critical factor in Slit2 signaling
pathway in the GC points to the possibility that Slit2 modulates
miR-182 function in this neuronal compartment. To test whether
Slit2 stimulation alters miR-182 activity directly in GCs, we elec-
troporated the miR-182-Sensor or control-Sensor into eyes and
made eye explant cultures (Figure 7A). Slit2 was bath applied to
these cultures at a concentration determined to induce a protein
synthesis-dependent response (Figure S7A). The fluorescence
levels of dGFP and mCherry in RGC GCs were then measured.
As expected, no change was detected in the dGFP/mCherry
fluorescence ratio upon Slit2 stimulation in control-Sensor-
expressing axons (+15% ± 10.5%) (Figures S7C and S7D). By
contrast, a significant increase in the dGFP/mCherry ratio
(+37.4% ± 10.8%) occurred upon Slit2 stimulation in the miR-
182-Sensor-expressing axons (Figures 7B and 7C). Expression
of the miR-182-Sensor or the control-Sensor did not affect
Slit2-induced GC collapse, because the presence of either
sensor does not alter GC responsiveness to Slit2 (Figure S7B).
We further investigated whether and which Slit2 receptor vari-
ants, Robos, are putatively involved in Slit2-mediated miR-182
regulation. Robo2 and Robo3, but not Robo1, are expressed in
XenopusRGCs (Hocking et al., 2010; Piper et al., 2006). Xenopus
Robo2 andRobo3 are, respectively, highly and poorly conserved
with their rodent counterparts. Whilemammalian Robo3 silences
Slit repulsion, non-mammalian Robo3 mediates it (Zelina et al.,
2014). Using an experimental paradigm similar to that used
earlier, we coelectroporated miR-182-Sensor with dominant-
negative rat Robo2 (dnRobo2) and dominant-negative Xenopus
Robo3 (dnRobo3) expression plasmids (Figure 7D). Dominant
negatives have been previously used to assess the role of
Robo signaling in axon guidance, including in Xenopus (Hocking
et al., 2010). Fluorescence analysis shows that the dGFP/
mCherry ratio is decreased in growth cones stimulated with
Slit2 when dnRobo2/3 was electroporated compared to control
(Figure 7E). Altogether, these data reveal that miR-182 is active
and represses Cfl1 translation in the axonal compartment under
basal conditions and that Slit2, via Robo2 and Robo3, inhibits its
repressive activity in RGC GCs.
A common mechanism to modulate the activity of miRNAs is
the regulation of their turnover or decay (R€uegger and Großhans,
2012). The Slit2-induced decrease in miR-182 activity in RGC
GCs could thus arise due to the degradation of miR-182; alterna-
tively, miR-182 could remain intact but be sequestered from itstargets. To examine this, we asked whether miRNA levels
changed in GCs following Slit2 stimulation by performing qRT-
PCR for miR-182 on RGC axons. RGC axons were collected
by LCM to avoid cell body contamination (Figures 7F and 7G),
and the purity of the axonal material was confirmed by the pres-
ence of b-actin and the absence of dendritic marker MAP2 and
nuclear marker histone H4 mRNA (Figure 7H). miR-182 levels
were unaltered in Slit2-treated axons compared to controls,
indicating that miR-182 is not degraded upon Slit2 signaling
(4.7% ± 10.9%) (Figure 7I). These results indicate that Slit2 trig-
gersmiR-182 inactivation in RGCGCswithout causing its degra-
dation and point toward the possibility of a reversible inactivation
and activation mechanism.
DISCUSSION
During development, navigating GCs contain a rich transcrip-
tome. Some of these transcripts are selected for translation
to mediate cue-induced GC steering. However, the regulatory
mechanisms conferring specificity of translation have remained
largely elusive. We have addressed here whether miRNAs could
contribute to the selection of specific transcripts for LPS in axon
guidance. We show that elongating Xenopus RGC axons have a
specific population of miRNAs and that miR-182 is enriched in
this neuronal compartment. Our data show that miR-182 acts
to modulate GC responsiveness to Slit2 in vitro and in vivo spe-
cifically within the tectum, where it plays a role in restricting
axons to the appropriate target area. miR-182 does so, at least
partly, by repressing the axonal translation of Cfl1, a key medi-
ator of Slit2-induced GC repulsion. Slit2, in turn, triggers both a
loss of activity of this miRNA, without leading to its degradation,
and a concomitant rise in Cfl1 LPS. Collectively, these results
indicate that the axon-enriched miR-182 is a key modulator of
Slit2-mediated LPS during guidance.
To understand whether miRNAs could act as specific regula-
tors of the axonal transcriptome, Next-Generation Sequencing-
based profiling was first performed. Such a high-throughput
unbiased approach has not been previously reported for axons.
This revealed a complex repertoire of miRNAs within axons and
GCs. Previous studies have documented not only the presence
but also the enrichment and depletion of miRNAs in this neuronal
compartment during development in various systems and or-
ganisms (Hancock et al., 2014; Natera-Naranjo et al., 2010; Sa-
saki et al., 2014), but the nature and abundance of miRNAs vary
broadly among these studies, including ours. The differences
could be attributed to variations in the types of cultures or meth-
odologies or to bona fide biological differences. In support of this
latter possibility, neurons of distinct types and stages express
varied pools of axonal transcripts (Gumy et al., 2011; Zivraj
et al., 2010). Some commonalities also appear. Rat superior cer-
vical ganglia (Natera-Naranjo et al., 2010) and mouse cortical
neurons (Sasaki et al., 2014) contain similar numbers of axonal
miRNAs. In addition, miR-182 is enriched in mouse dorsal root
ganglia distal axons (Hancock et al., 2014), and these cells
respond to Slit2 (Nguyen-Ba-Charvet et al., 2001). This suggests
that this miRNA might affect the axonal development in projec-
tion neurons regardless of cell type and species. It further indi-
cates that miR-182 might have a conserved role in modulatingCell Reports 18, 1171–1186, January 31, 2017 1181
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cue-mediated axon guidance. Overall, it is tempting to speculate
that each axon expresses a unique transcriptome and matching
miRNome, depending on the cellular requirements at a given
time of development, and that a limited set of conserved
mRNA-miRNA pairs regulates key GC behaviors.
A key question is whether miR-182 acts locally to regulate pro-
tein synthesis. Evidence presented here indicates that miR-182
represses Slit2-induced Cfl1 protein synthesis specifically at
the GC. First, miR-182 is present, abundant, and active in RGC
axons and GCs, as shown by small RNA sequencing analysis,
TaqMan PCR, in situ hybridization, and miRNA-Sensor-based
detection approaches in unstimulated cultures. Its absence in
RGC bodies by in situ analysis, together with its depletion in
RGC bodies compared to other retinal cells revealed by TaqMan
qPCR and the lack of miR-182-Sensor activity in RGC soma,
further suggests that this miRNA is enriched in axons and GCs.
miR-182 is thus likely to exclusively act in this compartment.
Second, translational repression of Cfl1 by miR-182 appears to
occur within GCs. In miR-182 morphants, Cfl1 protein immuno-
reactivity is increased specifically in this compartment, as de-
tected by quantitative immunofluorescence. In addition, Cfl1-30
UTR-driven expression of Kaede protein is higher in morphant
GCs. The possibility that miRNAs regulate local translation was
shown previously but not in the context of axon guidance.
Several reports have documented that axonal miRNAs control
levels of axonal protein (Aschrafi et al., 2008; Dajas-Bailador
et al., 2012; Hancock et al., 2014; Kar et al., 2013; Wang et al.,
2015; Zhang et al., 2013), including by modulating LPS of axonal
transcript (Hancock et al., 2014; Wang et al., 2015). These previ-
ous reports were conducted in neuronal culture to investigate
miRNA-regulated axon outgrowth. This study reveals that a
miRNA modulates cue-induced LPS to promote GC steering
during axon guidance. Along with the present dataset, these
findings highlight the importance of miRNAs, as a class of mole-
cule, in local regulation of translation within developing axons.
What might be the added value for the GC of this miRNA-medi-
ated LPS regulation? miRNAs could uniquely control the speci-
ficity of mRNA translation and contribute to selecting only a
limited set of axonal targets for translation from the numerous
pool of mRNAs present at the GC. In addition, miRNAs could
limit, or avoid, unwanted expression of their mRNA targets
outside the subregion of the GC close to cue exposure, thus
enhancing precise spatial control of LPS. Finally, because
miRNA action can be modulated, miRNAs may constitute an
additional layer of regulation that could help set the specific
time of LPS, avoiding spurious translation.Figure 7. Slit2 Inhibits miR-182 Activity in RGC Axons without Decay
(A, D, and F) Schematic representation of the experimental paradigm. Stage 35/
applied for 10 min.
(B) Illustrative images of GCs from miR-182-Sensor-electroporated RGCs grown
(C and E) Quantification of the dGFP/mCherry fluorescent ratio at the GC.
(G) Illustrative images of explants and axons before and after LCM.
(H) Illustrative gel of RT-PCR reaction for b-actin (b-act), MAP2, and histone H4 (H4
and b-act negative controls, PCR template was omitted.
(I) Quantification of miR-182 by the DDCt method in LCM axons.
Values aremean ±SEM (C, E, and I). Mann-Whitney test, *p < 0.05. ns, nonsignifica
Scale bars, 5 mm (B) and 200 mm (G). See also Figure S7.One finding is that Cfl1 LPS is not triggered by Slit2 exposure
in miR-182 morphant axons, as shown by immunofluorescence
and Kaede reporter construct. If miR-182 silences Cfl1 expres-
sion in the GC until a cue is encountered, Slit2-induced
Cfl1 translation should occur even in the absence of miRNA.
Several explanations can be provided for these results. First,
the elevated levels of Cfl1 detected in miR-182 morphant axons
may negatively feed back on Cfl1 LPS and prevent a further in-
crease in Cfl1 levels. In the absence of miR-182, Cfl1 LPS would
thus be uncoupled from Slit2 stimulation and Slit2 would be un-
able to affect the translational status of Cfl1 mRNA. Second,
miR-182 loss of function may deregulate additional direct tar-
gets, other than Cfl1, implicated in the Slit2 signaling cascade
or regulating LPS per se. In support of this, miR-182 is predicted
to silence cofactors of mTOR, as well as mitogen-activated
protein kinases (MAPKs) and associated or interacting proteins,
all known to be important for Slit2-induced Cfl1 LPS (Piper et al.,
2006). Furthermore, miR-182 is predicted to target a few tran-
scripts involved in translation and known to be present in
RGCs (Zivraj et al., 2010). Accordingly, miR-182 inactivation by
Slit2 would impinge on multiple pathways that would converge
to modulate Cfl1 LPS.
Although miRNAs were initially thought to be stable, the active
degradation of mature miRNAswas recognized as a key process
to modulate miRNA homeostasis (R€uegger and Großhans,
2012). This prompted us to investigate whether mature miR-
182 levels decrease upon Slit2 exposure. However, we do not
detect any change in miR-182 levels by qPCR. These results
contrast with a report documenting that miR-182 decays in neu-
rons within 90min of stimulation (Krol et al., 2010a). Because this
fast degradation was observed in mature neurons, but not in
immature neurons (Krol et al., 2010a), this discrepancy may be
explained by developing, and not fully differentiated, RGCs be-
ing used in the present work and/or by the varying type and
length of stimulus exposure employed. However, our finding is
in agreement with another study, which showed in dendritic
spines that BDNF lifts the repression that miR-134 exerts on
limk1 without altering the miRNA level (Schratt et al., 2006).
From this emerges a putative common regulatory mechanism
of miRNA inactivation in subregions of neurons not relying on
degradation. The loss of activity of miR-182 without its associ-
ated decay might be induced by RBPs. RBPs are reported to
compete with miRNAs for 30 UTR binding regions or to bind
directly to miRNAs, counteracting miRNA-mediated target
repression. RBPs also cooperate with miRNAs to regulate
mRNA silencing through shared mRNA cis-acting elements36 retinal explants were cultured for 24 hr, and then Slit2 or vehicle were bath
in culture. A clear example of dGFP/mCherry ratio increase is shown in (B).
) mRNA from cultured axons collected from stage 37/38 by LCM. InMAP2, H4,
nt; LCM, laser capturemicrodissection; RT, RT no template negative control.
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and/or through promoting and modulating RISC-mediated
repression (Gardiner et al., 2015; Krol et al., 2010b). It is thus
conceivable that Slit2 activates a competing RBP or inactivates
a cooperating RBP, and this in turn terminates miR-182-
mediated Cfl1 repression. One possible advantage of reducing
miRNA activity without clearing it from neuronal compartments
is that miRNAs can be readily available for future function without
the costly need to transcribe and ship new molecules to regions
far from the cell body. This type of reversible and bidirectional
mechanism would be particularly well suited to these compart-
ments, which are constantly exposed and respond rapidly to
various stimuli.
In conclusion, we provide evidence demonstrating that a
miRNA, miR-182, acts locally at the GC to confer selectivity of
Slit2-induced Cfl1 translation, pointing to the following model.
Under basal conditions, miR-182 keeps Cfl1 mRNA silent in
RGC axons. Upon Slit2 stimulation, miR-182 activity is abol-
ished in RGC GCs. This leads to the local de-repression of
Cfl1 mRNA and its concomitant translation in the GC, while
other mRNAs are kept silent by their own repressors. This local-
ized burst of Cfl1 de novo synthesis, in turn, locally affects the
cytoskeletal dynamics, subsequently inducing GC repulsive
turning. Conceptually, different axonal miRNAs might silence
different sets of mRNAs in the GC, preventing their LPS and
constituting a reserve pool of mRNAs ready to be translated
on demand. Inhibition of specific miRNA activity in the GC, in
response to acute stimulation by guidance cues, will therefore
act as a switch to relieve specific mRNAs from repression on
site in the GC. Such a mechanism could represent an efficient
way to ensure rapid selective translation, aiding the immediate
response of the GC.
EXPERIMENTAL PROCEDURES
Embryos
Xenopus laevis embryos were obtained by in vitro fertilization as previously
described (Cornel and Holt, 1992), raised in 0.13 modified Barth’s saline at
14C–22C, and staged according to Nieuwkoop and Faber (1994). All animal
experiments were approved by the University of Cambridge and University of
Trento Ethical Review Committees.
DNA plasmids, antisense oligonucleotides, and mimics used are described
in Supplemental Experimental Procedures.
Blastomere Microinjection
A total of 5 ng of morpholinos were injected into both dorsal animal blasto-
meres of eight-cell-stage embryos as described previously (Piper et al., 2008).
Electroporation
DNA constructs, morpholinos, or miR-182 mimics were electroporated in one
eye of stage 26 embryos, with conditions similar to those previously described
(Falk et al., 2007).
Optic Pathway Analysis
Stage 40 embryos were anesthetized and fixed in 4% paraformaldehyde (PFA)
for 2 hr to overnight. RGC axons were labeled by anterograde DiI filling of the
eye or directly visualized by mCherry fluorescence when electroporated.
Brains were dissected and mounted to visualize the optic tract on the contra-
lateral side of the brain. The z stacks of serial images comprising the entire
contralateral optic pathway were captured. Analysis on the width and the
length of the pathway were performed as previously described (Walz et al.,
2002), except that all measurements were normalized to brain size.1184 Cell Reports 18, 1171–1186, January 31, 2017Retinal Explant Culture
Whole retinas of anesthetized stage 35/36 or 37/38 embryos were dissected
and cultured at 20C for 24 hr, unless otherwise stated, in 60% L15 minimal
medium (Invitrogen) and 13 penicillin, streptomycin, and fungizone on glass
coverslips (Bellco) or glass-bottom dishes (MatTek) coated with poly-L-lysine
(10 mg/mL, Sigma) and laminin (10 mg/mL, Sigma).
Axonal Small RNA Sequencing
For 48 hr, 1,000 whole eye explants from stage 37/38 were cultured. Eye ex-
plants and contaminating cells were manually removed to isolate distal axons
only. Total RNA was extracted from both the axonal and the explant fractions
by phenol-chloroform extraction. The quality, quantity, and purity of the axonal
material were tested as described in Supplemental Experimental Procedures.
Small RNA libraries were prepared without pre-amplification, using the TruSeq
Small RNA Library Preparation Kit (Illumina) and sequenced on a MiSeq
sequencer (Illumina). Sequencing data analysis was performed as described
in Supplemental Experimental Procedures.
Laser Capture Microdissection
LCM of axons and RGC soma were performed on LMD6500 (Leica). The qual-
ity, quantity, and purity of the collected RNA were assessed as described in
Supplemental Experimental Procedures
Axons
Stage 35/36whole eye explants were cultured on RNase-DNase free polyester
(POL) membranes (Leica) for 24 hr and then processed for LCM as previously
described (Zivraj et al., 2010), except that 1% PFA was used instead. Distal
axons and explants from the same culture were collected in separate tubes.
RNA was extracted using the RNAqueous-Micro kit (Ambion). In vivo, laser
capture of axons was performed from stage 40 sections, and RNA was ex-
tracted using the Single Cell kit (Norgen).
RGC Soma
LCM of the RGC layer was performed on sectioned stage 40 embryos, and
stage 37/38 whole eyes were used as control. RNA was extracted using the
Total RNA Purification Kit (Norgen).
TaqMan qPCR for miR-182
Total RNA collected following LCM (described earlier) was retro-transcribed
using the TaqMan MiRNA Reverse Transcription Kit. The cDNA obtained
was used for the TaqMan Micro RNA assay using xtr-miR-182-5p and U6
snRNA-specific primers and probes and the TaqMan Universal Master
Mix II (MMIX II) no AmpErase Uracil N-Glycosylase (UNG) (all Thermo
Fisher). Reactions were run on a Bio-Rad CFX96 Real-Time System. For
quantitative analysis, cycle threshold (Ct) mean values were measured in
biological triplicates or more, and the DDCt method (Schmittgen and Livak,
2008) was applied as follows: fold change is 1/(2̂ [(CtmiR-182  CtU6)RGC 
(CtmiR-182  CtU6)eye]).
Quantitative Fluorescence Analysis
Quantitative Fluorescence of RGC GCs
Isolated GCs were selected at random with phase optics. To avoid subjective
bias, analyses were performed blind to the experimental condition. For each
experiment, all acquisitions were performed during the same day with the
same settings. The outline of each unsaturated GC was traced to define a re-
gion of interest (ROI), and the mean intensity of each channel was measured
using ImageJ or Leica Application SuiteX software. The background fluores-
cencewasmeasured in a ROI as close as possible to theGC selected and sub-
tracted to the GC mean fluorescence value.
Quantitative Fluorescence of Retinal Cells
Quantitation on cryosectioned retina pictures was performed as described
earlier, except that retinal cells in the photoreceptor (PR) layer and the inner-
most part of the inner nuclear layer were defined as the ROI.
GC Turning Assay
Turning assays were performed as described in Campbell and Holt (2001).
Further details are provided in Supplemental Experimental Procedures.
miRNA In Situ Hybridization
miRNA ISH protocols for (1) whole-mount, (2) cultured GCs, and (3) for retinal
sections were adapted from (1)Wienholds et al. (2005), (2) Han et al., 2011, and
from (3) Baudet et al. (2011) and Obernosterer et al. (2007). More details are
provided in Supplemental Experimental Procedures.
HRP Axon Tracing
HRP axon tracing and Slit2 ISH were performed as in Piper et al. (2006) on
stage 40 embryos. An overview of the HRP labeling protocol is available in
Supplemental Experimental Procedures.
Dual Luciferase Reporter Assay
Using Jet prime reagent (Polyplus Transfection), 250 ng of psiCHECK2-Cfl1-
WT-30 UTR or psiCHECK2-Cfl1-MUT-30 UTR were transfected with or without
12 pmol of control mimic or miR-182 mimic into HEK293T cells plated 12 hr
earlier on 48-well plates. The activity of both Renilla and Firefly luciferase
was measured 36 hr after transfection using the Dual Luciferase Reporter
Kit (Promega) and a DLReady TD-20/20 single-tube luminometer (Turner
Biosystems).
Live Imaging of the Kaede-Cfl1-30 UTR Translation Reporter in
Cultured Axons
After injection of control MO or miR-182 MO at the eight-cell stage, one eye
of the embryo was electroporated at stage 26 with pCS2+Kaede or
pCS2+Kaede-Cfl1-30 UTR reporter constructs. Electroporated eyes were
dissected at stage 36 and cultured for 24 hr to allow axonal growth. Before
cue stimulation, RGC axons were isolated from their cell bodies by manual
removal of the explant. Analysis of local translation of the Kaede reporter
was performed as previously described for the b-actin-30 UTR (Piper et al.,
2006, 2008). A brief description is available in Supplemental Experimental
Procedures.
Statistical Analysis
Each experiment was conducted at least three times unless otherwise stated.
For all tests, the significance level was a = 0.05. Data were analyzed with Prism
5 (GraphPad). The normal distribution of datasets was tested by the D’Agos-
tino and Pearson omnibus normality test. Statistical tests used are mentioned
in figure legends.
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Figure S1: Validation of axonal RNA purification and sequencing, Related to Figure 1. 
(A) Schematic representation of the experimental protocol. 1000 stage 37/38 eye explants were 
cultured. After 48h, explants were manually removed, and total RNA was extracted from the axonal 
fraction thus obtained. Small RNA cDNA libraries were generated and sequenced. (B) Representative 
images of 48h cultured stage 37/38 eye explant, before (left) and after (right) removal of the eye (star) 
and contaminating cells (arrowhead). Scale bar 300µm. (C) RT-PCR for MAP2 and β-actin mRNA 
performed on RNA extracted from the axonal or eye fraction. Both β-actin and MAP2 mRNA are 
detected in the eye fraction while only β-actin mRNA is detected in the axonal one, suggesting that the 
RNA extracted from the axonal fraction after removal of the explant is devoid of RNA contamination 
from cell bodies and dendrites. (D) Pearson correlation analysis of sequencing reads of axonal 
miRNAs between the two replicates. Values on axes show log2(cpm+1) for each sample. The Pearson 
correlation coefficient of 0.93 reported on top of the plot indicates a good correlation between the two 
replicates. (E) Illustrative gel showing TaqMan qPCR performed on RNA extracted from laser 
captured RGC layer detecting traces of miR-182 in RGC soma. RNA-U6 was used as a positive 












Figure S2: The activity of miR-182-Sensor inversely correlates with the expression of miR-182 in 
retinal cells, Related to Figure 2. 
(A) Schematic representation of the experimental protocol. miR-182- or control-Sensor (shown in Fig. 
2A) were electroporated in one eye at stage 26. Broken green line indicates the plane of section for the 
images shown in (B). (B) Representative images of endogenous miR-182 distribution detected by in 
situ hybridization on stage 40 retinal section. (C) Illustrative images of retina electroporated by 
control- or miR-182-Sensor. (D-E) Quantification of dGFP / mCherry fluorescence ratio in 
photoreceptor and amacrine cells following electroporation of control- or miR-182-Sensor. Values are 
mean ± SEM. Mann Whitney test. ***p< 0.001. ns, nonsignificant. 415 photoreceptor cells and 79 
amacrine-like cells (indicated in bars) were analyzed from three retinas per condition in total. (F) 
Illustrative gel following RT-PCR of dGFP and mCherry mRNAs on electroporated eye, collected at 
stage 37/38, and RGC axon collected by LCM from stage 40. To avoid detecting the parent plasmid, 
DNaseI treatment was carried out and RT was performed using oligo(dT). Presence of these two 
transcripts in axons indicates that Sensor construct is suitable to assess local activity of miR-182 in 
axons. GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; OPL, outer 
plexiform layer; PRL, photoreceptor layer; RPE, retinal pigmented epithelium; RT-, RT no template 












Figure S3: miR-182 MO efficiently knocks down endogenous miR-182 without affecting the 
generation of RGCs nor the growth of their axons, and miR-182 mimics rescues miR-182 
expression, Related to Figure 3. 
(A-E) Effect of the injection of control or miR-182 MOs in both dorsal blastomeres at eight cell stage 
embryos, driving the expression of the morpholino in the central nervous system, in Xenopus laevis 
embryos at stage 37/38 and 40. (A) Schematic of the experimental protocol and representative images 
of control and miR-182-injected embryos at stage 40. No major difference was observed between 
controls and miR-182 morphants morphology. (B) Representative images of ISH signal for control or 
miR-182 probes on stage 37/38 control or miR-182 morphant embryos. Most of the ISH signal for 
miR-182 in neural cells disappears in presence of miR-182 MOs, suggesting that miR-182 MOs 
efficiently knockdown endogenous miR-182. (C) Quantification of the size of the eye of control and 
miR-182 morphant embryos at stage 40 shows no significant differences between the two populations. 
(D) Representative images of cryosections of the eye of control or miR-182 morphant embryos at stage 
40, at the level of the optic nerve head, after immunolabeling for Sox2 (red) and Islet1 (green) and 
counterstaining with DAPI (blue). (E) Quantification of the number of RGCs, per section, in stage 40 
control or miR-182 morphant embryos. No significant difference was observed. (F) Schematic 
representation of the quantification method after injection in dorsal blastomeres or electroporation in 
the eye of control or miR-182 MOs, and DiI labeling of the RGC axons. The length of axons was 
assessed by measuring the distance from the optic chiasm to the longest RGC axons (l) normalized to 
the size of the brain from the optic chiasm to the posterior boundary of the tectum (L). (G-H) Graph 
showing the quantification of RGC axon length in control and miR-182 MOs injected (G) or 
electroporated (H) embryos. No significant difference in RGC axon length was detected in absence of 
miR-182. (I) Representative images of ISH for miR-182 on vibratome section of stage 37/38 morphant 
embryos after eye electroporation of control- or miR-182 mimics in the eye. Exogenous miR-182 
mimics, but not control mimics, were detected in electroporated retinal areas (delineated by a dashed 
black line) in a miR-182 morphant background. Through the figure: values are mean ± SEM. Numbers 
of eye/embryo (C), retinal sections (E) and brains (G, H) analyzed are indicated within bars. All 
samples passed D’Agostino & Pearson Omnibus normality test. Student’s t-test. ns, nonsignificant 









Figure S4: MO-mediated Slit2 knockdown affects the size of the eye, Related to Figure 4. 
(A) Representative images of stage 40 embryos whose dorsal blastomeres have been injected with 
control or Slit2 MOs at 8 cell stage. (B-C) The efficiency of Slit2 knockdown was assessed by 
Western Blot. (B) Representative western blot for Slit2 and α-tubulin of head lysates from stage 40 
control or Slit2 morphants. (C) Quantification of Slit2/ α-tubulin intensity ratio (n=3) shows a drastic 
reduction of Slit2 expression in the presence of Slit2 MO in the nervous system. Values are mean ± 
SEM. Wilcoxon paired test, **p<0.01. ns, nonsignificant; cont, control; MO, morpholino. Scale bar, 





Figure S5: miR-182 is not required for Sema3A-induced repulsive turning of RGC axons in 
vitro, Related to Figure 4. 
In vitro turning assay on stage 35/36 RGC axons cultured for 24h and isolated from their cell bodies. 
(A) Representative images of control or miR-182 morphants RGC GC before and 60 minutes after 
being exposed to a gradient of Sema3A established from a pipette (top right corner) set at 45° angle 
from the initial direction of growth. Scale bar, 30µm. (B) Tracings of RGC axons analyzed. Source of 
guidance cue is indicated by arrowhead. Red, black and blue traces represent, respectively repulsive 
behaviors (angle <-5°), nonsignificant changes in the direction of growth (-5°<angle<5°), and 
attractive turning (angle >5°). (C) Quantification of the average turning angle ± SEM. Numbers of 









Figure S6: Basal expression level of Kaede-cofilin1 construct in RGC growth cones is regulated 
by miR-182, Related to Figure 6. 
Comparison of the basal expression levels of Kaede-cofilin1 in control or miR-182 morphant RGC 
growth cones in vitro. (A) Representative images of control or miR-182 morphant Kaede-cofilin1 
expressing growth cones. Scale bar, 10µm. (B) Quantification of Kaede fluorescent signal in control or 
miR-182 morphant growth cones. miR-182 knockdown increases the basal expression level of Kaede-
cofilin1 in RGC growth cones. Values are mean ± SEM. Numbers of growth cones analyzed are 










Figure S7: Protein synthesis-dependent Slit2-induced collapse is not affected by the expression of 
miR-182 activity Sensor, Related to Figure 7. 
(A) Quantification of collapsed growth cones from stage 35/36 retinal explants cultured for 24h 
following 10 min 100ng/mL or 200ng/mL Slit2 stimulation by bath application in the presence or 
absence of the translational blocker cycloheximide (CHX). At 200ng/mL a Slit2-induced PS-
dependent collapse was observed. (B) Quantification of collapsed growth cones from stage 35/36 
retina from wildtype embryos or embryos electroporated at stage 26 with control or miR-182-Sensor 
(shown in Fig. 2A), cultured for 24h and stimulated for 10 min by 200ng/mL Slit2 or PBS control. (C) 
Representative images of GCs following retinal electroporation of control-Sensor. (D) Quantification 
of dGFP / mCherry fluorescent ratio directly at the GC following 10 min Slit2 or PBS control bath 
application. Mann Whitney Test. (E) Quantification of collapsed growth cones from stage 35/36 retina 
from wildtype embryos or embryos electroporated at stage 26 with miR-182-Sensor and/or pCS2-
dnRobo2-MT and pCS2-dnRobo3-MT, cultured for 24h and stimulated for 10 mins by 200ng/mL Slit2 
or PBS control. Collapse was significantly reduced by 18% following electroporation of dnRobo2/3. 
Residual collapsed growth cones might be due to the fact that not all RGCs are targeted by 
electroporation. Values are mean ± SEM. Numbers of growth cones analyzed are shown within bars. 
Two-way ANOVA followed by Sidak multiple comparison test (A,B). *p<0.05; **p<0.01. (B) Not 
displayed on graph: WT, ****p < 0.0001; control-Sensor, *p<0.05; miR-182-Sensor, **p < 0.01. One-
way ANOVA followed by Sidak multiple comparison post hoc test (E). ***p< 0.001; ****p < 0.0001. 




Table S1: RGC axon miRNA profiling data, Related to Figure 1. 
The table presents the sequencing data of mature miRNAs from axonal sRNA-Seq libraries prepared from 
two independent axonal preparation of stage 37/38 retinal cultures (sample 1 and 2). For each library, the 
counts-per-million (cpm) were calculated by dividing the number of reads mapping to each miRNA 
(column 2 and 3) by the total reads from that library and multiplying by 1 million. For display purposes a 
count of 1 was added to each cpm, log2-transformed, and the mean was then calculated for each miRNA 
(column 4). The relative abundance in percentage was also calculated (column 5-7). The table is sorted by 
decreasing axonal cpm values. 
 
 
Table S2: Predicted miR-182 targets expressed in Xenopus laevis growth cones at stage 32, Related 
to Figure 5. 
The table presents predicted miR-182 targets expressed in stage 32 growth cones grown in culture for 24h 
(equivalent to in vivo stage 37/38) ranked by their TargetExpress scores (column 9). The TargetExpress 
score is based on the expression level for each gene (column 6) and their respective TargetScan Context+ 
score (column 7) for miR-182-5p. Average expression levels for each gene in stage 32 growth cones were 
obtained after vsnrma normalization of Xenopus laevis growth cone microarray data (GEO: GSE25166). 





Supplemental Experimental Procedures 
 
Antisense oligonucleotides and mimics. FITC labeled and/or unlabeled antisense oligo morpholinos 
(MO) for xtr-miR-182 (5′-TGTGAGTTCTACCATTGCCAAA-3′), xla-Slit2-S (5’-
ACTGAGGTCACTGTGGATAAAAAGA -3’, xla-Slit2-L (5’-
TGACTGCTGACCTGAAAATTAAAGT-3’), control (5′-GTGTAACACGTCTATACGCCCA-3′) 
and standard control MOs (5′-CCTCTTACCTCAGTTACAATTTATA-3′) were obtained from Gene 
Tools. miR-182 mimics (miRIDIAN mimic 5’-UUUGGCAAUGGUAGAACUCACA-3’) and control 
mimics (miRIDIAN mimic negative control #1, 5′-UCACAACCUCCUAGAAAGAGUAGA-3′) were 
purchased from GE healthcare-Dharmacon. 
 
DNA plasmids. miR-182-Sensor was generated as follows. d2GFP (destabilized GFP) from 
pd2EGFP-N1 vector (ClonTech) was subcloned into a pCS2+ vector, downstream of a CMV 
promoter. The first 150 nt of the 3’UTR of the Caenorhabditis elegans myosin heavy chain (unc54) 
gene (J01050.1), known to have no vertebrate miRNA binding sites (De Pietri Tonelli et al., 2006), 
and three fully complementary sequences to the Xenopus laevis miR-182, separated by 8 nt spacer, 
were then placed 3’ of the d2GFP (GenScript, Hong Kong). Finally, CMV-mCherry-SV40 was 
subcloned from a pCS2-mCherry parent vector into the pCS2-d2GFP-miR-182 plasmid to generate 
miR182-Sensor. The corresponding negative control plasmids, control-Sensor, was generated by 
inserting three tandem cassettes with an arbitrary sequence not complementary to any known miRNA 
(De Pietri Tonelli et al., 2006) instead of the three complementary sequences to miR-182. 
pCS2+ Kaede-cofilin1-3′UTR reporter was generated by cloning CoralHueTM Kaede (Bam HI/PstI 
blunt) into pCS2+ plasmid (BamHI/StuI). The 3’UTR of Xenopus laevis cofilin1 was amplified by 
PCR. The amplified fragment was cloned in the KpnI/XhoI sites of pCS2+Kaede.  
psiCHECK2-cofilin1-WT-3’UTR luciferase construct was generated by extraction of cofilin1-3’UTR 
from pCS2+ Kaede-cofilin1-3′UTR by XhoI/KpnI and insertion into the multiple cloning site of the 
Renilla: firefly luciferase-expressing vector psiCHECK2 (Promega). psiCHECK2-cofilin1-MUT-
3’UTR was generated by site-directed mutagenesis using QuickChange II XL kit (Agilent 





pCS2-XenopusdnRobo3-MT and pCS2-Igk-ratdnRobo2-MT (Hocking et al., 2010) were kind gifts 
from Sara McFarlane (University of Calgary, Canada). pCS2-ratdnRobo2-MT used in this study was 
obtained from pCS2-Igk-RatdnRobo2-MT by removal of Igk and rat Robo2 5’UTR sequences.  
 
Quality, quantity and purity of axonal RNA. The quality and quantity of the RNA was determined 
by Bioanalyzer (Agilent 2100) and Qubit (Life Technologies now Thermo Fisher Scientific), 
respectively. The purity of the axonal RNA was assessed by the presence of β-actin but not MAP2 
mRNA or histone H4 mRNA by RT-PCR. DNA oligos used for PCR were the following: β-actin 
mRNA, 5’- CGTAAGGACCTCTATGCCAA-3’ and 5’- TGCATTGATGACCATACAGTG-3’; 
MAP2 mRNA, 5’- TCAATGGAGAAATGCCATCA-3’ and 5’- TGAATGGAGGAAGGTCTTGG-
3’; Histone H4 mRNA, 5’-GGCAAAGGAGGAAAAGGACT-3’ and 5’-
GAGAGCGTACACCACATCCA. 35-40 cycles were performed at 60°C.  
 
small RNA sequencing data analysis. The sequencing results from the sRNA axonal libraries were 
3’-adapter trimmed and de-duplicated using the reaper and tally command-line tools from Kraken 
(Davis et al., 2013). The processed sRNA-Seq reads were mapped to all available Xenopus tropicalis, 
Xenopus laevis and Danio rerio pre-miRNA sequences (miRBase v21, (Kozomara and Griffiths-Jones, 
2014)). Read mapping was performed using Bowtie (Langmead et al., 2009). The mapping process 
was performed in four steps: 1) mapping all reads, allowing 0 mismatches, 2) mapping only reads 
failing to map in the previous step and longer than 10 nucleotides, allowing 1 mismatch, 3) mapping 
only reads failing to map in the previous step and longer than 20 nucleotides, allowing 2 mismatches 
and 4) mapping only longer reads failing to map in the previous step, allowing 3 mismatches. To 
eliminate redundancy between pre-miRNAs mapped to the same genome location, pre-miRNAs were 
mapped to the Xenopus laevis genome (downloaded from 
ftp://ftp.xenbase.org/pub/Genomics/JGI/Xenla6.0/). Pre-miRNAs mapped to Xenopus laevis with 
identity < 80% were discarded. Many pre-miRNAs could map to the same genome location with 
identity > 80%, so we ordered them according to identity and kept the pre-miRNA with the highest 
	
score. We did not impose a species name preference for identity ties, we simply kept the first one. 
Quantification of mapped reads that overlapped with non-redundant pre-miRNAs and mature miRNA 
regions was performed using the R package GenomicRanges [R Core Team (2015). R: A language and 
environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL 
http://www.R-project.org (Lawrence et al., 2013)]. The minimum overlap required between mapped 
reads and mature regions was 16 nt. We collapsed mature counts by mature miRNA id regardless of 
species name. All RNA-seq data are deposited in Gene Expression Omnibus (GEO) datasets under 
accession number GSE86883. 
 
miR-182 Target prediction: Microarrays from Xenopus laevis growth cones were downloaded from 
GEO (GSE25166), and normalized together using vsnrma from the vsn R package (Huber et al., 
2002). The average expression of the stage 32 growth cone (grown in culture for 24h, thus 
corresponding to in vivo stage 37/38) samples (GSM618289, GSM618290, GSM618291, 
GSM618292) was calculated. Xenopus laevis gene models (1.8.3.2) and their annotation on the X. 
laevis v9.1 genome were downloaded from Xenbase 4.0 (http://www.xenbase.org/, 
RRID:SCR_003280) (James-Zorn et al., 2015; Karpinka et al., 2015). The 3’UTR sequences from all 
protein-coding transcripts were obtained using a custom R script with Biostrings (Pages H. et al. 2016) 
and bedtools (Quinlan and Hall, 2010). TargetScan Context+ scores were calculated for all miR-182-
5p potential targets using the perl script downloaded from 
http://www.targetscan.org/vert_61/vert_61_data_download/targetscan_61_context_scores.zip (Garcia 
et al., 2011). Transcripts with the same Gene Symbol (ignoring L/S variants) were collapsed, selecting 
the one with the best Context+ score. Genes without any assigned GO term, or not represented on the 
Affymetrix Xenopus laevis Genome Array were excluded from further analyses. Finally, the stage 32 
growth cone expression of each gene was combined with the TargetScan Context+ score, using the 
TargetExpress method (Ovando-Vazquez et al., 2016). This method allows to prioritize predicted 
targets that are likely to be functional based on their expression level in the cell type of interest. 
 
Growth cone turning assay. Gradients of Slit2 recombinant protein (R&D) were established as 
described in (Campbell and Holt, 2001) by ejecting 10 µg/mL Slit2-containing medium or control 
medium out of a micropipette with a tip opening of 1µm. Single growth cones, isolated from their cell 
bodies, from stage 35/36 retinal explants cultured for 24h were positioned 100µm from the tip opening 
at an angle of 45° relative to the initial direction of the axon shaft. Pictures were taken every 5 min for 
1 hr. Turning angles were measured using ImageJ software.  
 
Horseradish peroxidase (HRP) axon tracing. The right lens of anesthetized stage 40 embryos was 
removed. A paste made of 1% (wt/vol) L-α-lysolecithin (Calbiochem) containing HRP (Roche) was 
applied in the lensless ocular cavity. After 1h, embryos were fixed in 4% PFA, brains were dissected 
out and incubated with a 3,3′-diaminobenzidine tetrahydrochloride (Sigma) in 0.1% H2O2 solution to 
reveal HRP staining in RGC axons. Post fixation, ISH for Slit2 was performed, as described 
previously (Piper et al., 2006). Brains were mounted in lateral view and imaged on a Zeiss Axioskop 
microscope. 
 
Live imaging of Kaede-cofilin1-3′UTR translation reporter and analysis. Briefly, after initial 
imaging, Kaede-green is photoconverted to Kaede-red by 6-8 sec exposure to UV light. Axons were 
then stimulated with suboptimal concentration of Slit2 (125ng/mL) to prevent growth cone collapse, 
and images were acquired every 5 min on a Nikon Eclipse TE2000-U inverted fluorescence 
microscope for 30 min. For the analysis, the outline of the growth cone was manually traced in ImageJ 
software to define a ROI, and both Kaede-green and Kaede-red fluorescence intensity were measured. 
All measurements were performed on growth cones with non-saturated signal.  
 
Collapse assay. Retinal explants were bathed in 200ng/ml human recombinant Slit2 (R&D) for 10 
min with or without cyclohexamide and then fixed in 2% PFA, 7.5% (wt/vol) sucrose. To avoid 
subjective bias, all collapse analysis was done blind to experimental condition. Growth cones were 
considered collapsed when they possessed two or fewer filopodia each shorter than 10µm.  
 
Western Blot. The head of anesthetized stage 37-38 embryos were dissected, homogenized and lysed 
in RIPA buffer (Sigma) containing cOmplete Mini EDTA-free protease inhibitor cocktail (Roche). 
Centrifugation at 4°C was performed to clear the lysates. Western-Blot was done using rabbit anti-
Slit2 (1/500, Genetex) or mouse anti-α-tubulin (1/5000, Sigma), and horseradish peroxidase-
conjugated anti-rabbit or anti-mouse secondary antibody (1/5000, Abcam). 
	
 
RT-PCR for Sensor construct in axons. Control-Sensor electroporated eyes were dissected at stage 
37/38 and axons were collected by laser capture microdissection from stage 40 cryosections. Total 
RNAs were subsequently extracted with Norgen Total (for eyes) or single cell (for axons) RNA 
Purification Kit and retrotranscribed with SuperScript IV (ThermoFisher) using oligo(dT) primers. The 
cDNA obtained was amplified for 40 cycles using the following primers: (5’-
CACATGAAGCAGCACGACTT-3’ Fw d2GFP, 5’-TGCTCAGGTAGTGGTTGTCG-3’ Rv d2GFP, 




Whole-mount miRNA ISH: miRNA ISH were performed as previously described (Wienholds et al., 
2005) on stage 38 or 40 fixed embryos using 2nM DIG-labelled LNA oligonucleotide probes.  
miRNA ISH on GCs: Fluorescent ISH (FISH) for miRNA was performed on 24h stage 35/36 retinal 
cultures with a protocol adapted from (Han et al., 2011). Hybridization was performed with 10-15nM 
DIG-labelled LNA oligonucleotide probes at 22°C below the predicted Tm. After extensive washes, 
the ISH signal was detected using anti-digoxygenin antibody conjugated to HRP (Roche) and the 
fluorescence signal generated by Cy3-tyramide amplification system (PerkinElmer). Retinal cultures 
were then mounted in ProLong Gold Antifade mountant. FISH signal in RGC GCs was imaged using 
an Olympus FV1000 confocal microscope equipped with GASP detectors.  
miRNA ISH on retinal sections: ISH was carried out on transverse cryosections or vibratome section 
of stage 40 fixed embryos, as previously described (Baudet et al., 2012; Obernosterer et al., 2007).  
 
Immunostaining. 12µm thick transverse cryosections of fixed stage 40 embryos or stage 35/36 retinal 
cultures were stained with the following antibodies. Mouse anti–Islet-1 (40.2D6, 1:500, 
Developmental Studies Hybridoma Bank), rabbit anti-Sox2 (1:500, Millipore) and rabbit anti-cofilin1 
(1/200, kindly provided by J. Bamburg). Secondary antibodies were goat anti-mouse Alexa Fluor 488–
and goat anti-rabbit Alexa Fluor 555–conjugated F(ab’)2 fragments (Invitrogen). Sections were 
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